High cumulative glucocorticoid dose is associated with increased levels of inflammation-related mediators in active rheumatoid arthritis
IntroductionGlucocorticoids (GCs) are widely used as a treatment for rheumatoid arthritis (RA), leading to high cumulative doses in long-term treated patients. The impact of a high cumulative GC dose on the systemic inflammatory response in RA remains poorly understood.MethodsWe investigated long-tr...
Saved in:
| Main Authors: | Anna Petrackova, Pavel Horak, Jakub Savara, Martina Skacelova, Eva Kriegova |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-12-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1505615/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of the modified combined glucocorticoid toxicity index in rheumatoid arthritis: Preliminary data
by: V. V. Lebedeva, et al.
Published: (2020-02-01) -
Revisiting the question of the safety of glucocorticoids use of in the treatment of rheumatoid arthritis
by: E. A. Aronova, et al.
Published: (2023-07-01) -
Adverse effects of oral glucocorticoid therapy - a brief review of literature
by: Marta Gruszka, et al.
Published: (2025-02-01) -
Is it possible to discontinue glucocorticoids in rheumatoid arthritis with the use of synthetic disease-modifying antirheumatic drugs?
by: O. B. Iaremenko, et al.
Published: (2023-07-01) -
Comparison of different intervention thresholds for the treatment of glucocorticoid-induced osteoporosis: a cross-sectional study
by: Kanchalee Puksun, et al.
Published: (2025-04-01)